ONEOK, Inc. (OKE) Market Cap & Valuation Ratios
ONEOK, Inc. (OKE) has a market cap of $60.4B, a trailing P/E of 16.5 and a price-to-sales ratio of 1.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OKEONEOK, Inc.Follow OKE — free
—
Price chart with a free account
- Market cap
- 60.4B
- P/E TTM
- 16.5
- Dividend yield
- 4.4%
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Peers
oil & gas midstream · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| OKE | 60 | 16.5 | 2.4 | 12.2 | 4.8% | +41% | 16% | 8% |
| ENB | 105 | — | — | — | — | +29% | 13% | 5% |
| WMB | 88 | 28.6 | 9.7 | 16.9 | -0.1% | +9% | 38% | 9% |
| KMI | 77 | 21.3 | 5.9 | 13.9 | 4.0% | +12% | 29% | 7% |
| TRP | 65 | — | — | — | — | +11% | 53% | 7% |
| TRGP | 65 | 28.9 | 5.0 | 15.4 | 1.1% | -2% | 23% | 14% |
| LNG | 62 | 22.5 | 3.9 | 10.8 | 4.5% | +18% | 30% | 19% |
| VNOM | 17 | 156.1 | 9.0 | 17.3 | — | +108% | 12% | 2% |
| DTM | 13 | 27.1 | 12.1 | 17.2 | 3.8% | +18% | 50% | 6% |
| AM | 9.9 | 24.8 | 10.9 | 15.5 | 7.8% | +7% | 53% | 9% |
| KNTK | 9.0 | — | 6.9 | 21.6 | 1.7% | +14% | 11% | 7% |
| Median of these 10 | 27.1 | 8.0 | 16.2 | 3.8% | +13% | 29% | 7% |
P/E 16.5 vs. a peer median of 27.1; EV/Sales 2.4 vs. 8.0. OKE's own P/E sits at the 52nd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesENB and TRP and KNTK have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
ONEOK, Inc. — questions
- What is ONEOK, Inc.'s market cap?
- $60.4B.
- What is ONEOK, Inc.'s P/E ratio?
- 16.5 on trailing twelve-month earnings to 2026-06-30.
- What is ONEOK, Inc.'s price-to-sales ratio?
- 1.5.
Every figure on this page comes from ONEOK, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.